Kuros Biosciences Ltd (CSBTF)
7.10
-1.95
(-21.55%)
USD |
OTCM |
Apr 30, 11:02
Kuros Biosciences 1 Year Total Returns (Daily): 378.8% for April 29, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 29, 2024 | 378.8% |
| April 26, 2024 | 378.8% |
| April 25, 2024 | 378.8% |
| April 24, 2024 | 378.8% |
| April 23, 2024 | 378.8% |
| April 22, 2024 | 378.8% |
| April 19, 2024 | 341.8% |
| April 18, 2024 | 340.7% |
| April 17, 2024 | 340.7% |
| April 16, 2024 | 321.4% |
| April 15, 2024 | 359.8% |
| April 12, 2024 | 359.8% |
| April 11, 2024 | 354.0% |
| April 10, 2024 | 318.0% |
| April 09, 2024 | 265.1% |
| April 08, 2024 | 254.2% |
| April 05, 2024 | 257.1% |
| April 04, 2024 | 257.1% |
| April 03, 2024 | 246.6% |
| April 02, 2024 | 246.6% |
| April 01, 2024 | 238.6% |
| March 28, 2024 | 228.1% |
| March 27, 2024 | 225.5% |
| March 26, 2024 | 225.5% |
| March 25, 2024 | 225.5% |
| Date | Value |
|---|---|
| March 22, 2024 | 212.5% |
| March 21, 2024 | 212.5% |
| March 20, 2024 | 212.5% |
| March 19, 2024 | 212.5% |
| March 18, 2024 | 212.5% |
| March 15, 2024 | 212.5% |
| March 14, 2024 | 212.5% |
| March 13, 2024 | 212.5% |
| March 12, 2024 | 228.1% |
| March 11, 2024 | 213.3% |
| March 08, 2024 | 188.5% |
| March 07, 2024 | 188.5% |
| March 06, 2024 | 220.3% |
| March 05, 2024 | 212.5% |
| March 04, 2024 | 212.5% |
| March 01, 2024 | 212.5% |
| February 29, 2024 | 214.5% |
| February 28, 2024 | 214.5% |
| February 27, 2024 | 214.5% |
| February 26, 2024 | 214.5% |
| February 23, 2024 | 238.5% |
| February 22, 2024 | 275.0% |
| February 21, 2024 | 275.0% |
| February 20, 2024 | 254.2% |
| February 16, 2024 | 254.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.12%
Minimum
Dec 18 2019
582.2%
Maximum
Dec 18 2020
35.13%
Average
-1.56%
Median
May 10 2023
1 Year Total Returns (Daily) Benchmarks
| AC Immune SA | 23.71% |
| CRISPR Therapeutics AG | 12.04% |
| Addex Therapeutics Ltd | -46.88% |
| NLS Pharmaceutics Ltd | -89.35% |
| Molecular Partners AG | -43.85% |